SENSEX NIFTY

Tablets

May 02, 2016 at 14:44 | Source: Moneycontrol.com
The company has announced that USFDA has granted approval for an Abbreviated New Drug Application (ANDA) for Metformin Hydrochloride extended-release tablets USP 500 mg and 750 mg.
May 02, 2016 at 14:02 | Source: Moneycontrol.com
Marksans Pharma announced that USFDA has granted approval for an ANDA for Metformin Hydrochloride extended-release tablets USP 500 mg and 750 mg.
May 02, 2016 at 13:32 | Source: PTI
"The company has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lacosamide tablets, 50 mg, 100 mg, 150 mg and 200 mg," Alembic Pharmaceuticals said in a BSE filing.
Apr 29, 2016 at 14:08 | Source: PTI
"The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Lacosamide tablets, 50 mg, 100 mg, 150 mg and 200 mg," Aurobindo Pharma said in a filing on BSE.
Apr 28, 2016 at 09:54 | Source: PTI
The tablets in the strength of 80 mg are made by Torrent for its US arm Torrent Pharma Inc, the latest US Food and Drug Administration (USFDA) enforcement report said.
Apr 27, 2016 at 12:36 | Source: PTI
Aurobindo Pharma today said it has received final approval from the US health regulator tomanufacture and market generic version of heartburn relief medicine Famotidine tablets.
Apr 26, 2016 at 15:04 | Source: Moneycontrol.com
The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Amlodipine and Valsartan Tablets USP, 5mg/160mg, 10mg/160mg, 5mg/320mg and 10mg/320mg.
Apr 26, 2016 at 11:24 | Source: PTI
Glenmark Pharmaceuticals USA has been granted tentative approval by the USFDA for Norethindrone Acetate and Ethinyl Estradiol tablets USP, 1 mg/0.01 mg, Ethinyl Estradiol tablets USP, 0.01 mg and Ferrous Fumarate tablets, 75 mg, the generic version of Lo Loestrin Fe, the company said in a BSE filing today.
Apr 26, 2016 at 11:16 | Source: Moneycontrol.com
Aurobindo Pharma has received final approval from the USFDA to manufacture and market Amlodipine and Valsartan Tablets USP, 5mg/160mg, 10mg/160mg, 5mg/320mg and 10mg/320mg.
Apr 26, 2016 at 10:50 | Source: Moneycontrol.com
Glenmark Pharmaceuticals Inc. USA has been granted tentative approval by the USFDA for Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1 mg/0.01 mg, Ethinyl Estradiol Tablets USP, 0.01 mg and Ferrous Fumarate Tablets, 75 mg.
Messages on Tablets »

kalpataru70

Platinum Member

497 Followers

Aurobindo Pharm  

Aurobindo Pharma has opened in the green on the bourses as it gets US FDA`s nod for Ritonavir tablets. This medicine is used to treat HIV/AIDS.

2.20 PM Jan 19th

Chari_2014

New Member

7 Followers

Panacea Biotec  

regulator to market a generic version of Merck & Co`s Maxalt-MLT tablets, used in treating migraine, in the American market. Commenting on the developments, Panacea Biotec Joint Mag Director Rajesh Jain said that another product approval by USFDA and UN Agencies business would help the company to grow

12.27 PM Jan 19th

k.v.renga

Platinum Member

1368 Followers

Panacea Biotec  

Source:----BL:----) January 18, 2017: Panacea Biotec on Wednesday said the US Food and Drug Administration has approved the company s abbreviated new drug application for rizatritan benzoate orally disintegrating tablets of 5 mg and 10 mg strengths, which is the generic equivalent of Maxalt

9.26 PM Jan 18th

Wire News

Platinum Member

694 Followers

News Now  

Drug firm Zydus Cadila today said it has received approval from the US health regulator to market methotrexate tablets, a chemotherapy drug, in the American market.

4.44 PM Jan 18th

vinaykunu

New Member

1 Followers

Cadila Health  

good news approval of cancer tablet.

4.16 PM Jan 18th

BSE/NSE Announcer

Platinum Member

20332 Followers

Cadila Health  

Cadila Healthcare Limited has informed the Exchange regarding a press release dated January 18, 2017, titled "Zydus receives final approval from the USFDA for Methotrexate Tablets USP.".

3.30 PM Jan 18th

BSE/NSE Announcer

Platinum Member

20332 Followers

Cadila Health  

Zydus Cadila has received the final approval from the USFDA to market Methotrexate tablets USP, 2.5 mg, a chemotherapy drug used for leukemias, lymphomas, breast cancer, lung cancer, and head and neck cancer and other cancers.

3.16 PM Jan 18th

BSE/NSE Announcer

Platinum Member

20332 Followers

Cadila Health  

Cadila Healthcare Ltd has submitted to BSE a copy of Press Release dated January 18, 2017 titled Zydus receives final approval from the USFDA for Methotrexate Tablets USP".

3.04 PM Jan 18th

  

Flupirtine male ate and paracetamol tablets

2.11 PM Jan 18th

BSE/NSE Announcer

Platinum Member

20332 Followers

Panacea Biotec  

Panacea Biotec announces that United States Food and Drug Administration (USFDA) has granted approval for ANDA to market a generic version of Rizatriptan Benzoate Tablets, Orally disintegrating, 5 mg and 10 mg.

12.39 PM Jan 18th

News across the web »
Sep 02, 2016 at 17:44 | Source: FirstPost
Aug 26, 2016 at 18:38 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.